Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
Published on: June 28, 2024
Characterization of vB_SauM-fRuSau02, a Twort-Like Bacteriophage Isolated from a Therapeutic Phage Cocktail
Katarzyna Leskinen1, Henni Tuomala2,3, Anu Wicklund4,5
1Department of Bacteriology and Immunology, Medicum, Research Programs Unit, Immunobiology Research Program, University of Helsinki, Helsinki 00290, Finland. katarzyna.leskinen@helsinki.fi.
Abstract:
Staphylococcus aureus is a commensal and pathogenic bacterium that causes infections in humans and animals. It is a major cause of nosocomial infections worldwide. Due to increasing prevalence of multidrug resistance, alternative methods to eradicate the pathogen are necessary. In this respect, polyvalent staphylococcal myoviruses have been demonstrated to be excellent candidates for phage therapy. Here we present the characterization of the bacteriophage vB_SauM-fRuSau02 (fRuSau02) that was isolated from a commercial Staphylococcus bacteriophage cocktail produced by Microgen (Moscow, Russia). The genomic analysis revealed that fRuSau02 is very closely related to the phage MSA6, and possesses a large genome (148,464 bp), with typical modular organization and a low G+C (30.22%) content. It can therefore be classified as a new virus among the genus Twortlikevirus. The genome contains 236 predicted genes, 4 of which were interrupted by insertion sequences. Altogether, 78 different structural and virion-associated proteins were identified from purified phage particles by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The host range of fRuSau02 was tested with 135 strains, including 51 and 54 Staphylococcus aureus isolates from humans and pigs, respectively, and 30 coagulase-negative Staphylococcus strains of human origin. All clinical S. aureus strains were at least moderately sensitive to the phage, while only 39% of the pig strains were infected. Also, some strains of Staphylococcus intermedius, Staphylococcus lugdunensis, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus saprophyticus and Staphylococcus pseudointer were sensitive. We conclude that fRuSau02, a phage therapy agent in Russia, can serve as an alternative to antibiotic therapy against S. aureus.
Insights
Bacteriophage fRuSau02 shows promise as a phage therapy agent against Staphylococcus aureus infections. This research characterizes its genome and demonstrates its effectiveness against clinical S. aureus strains, offering an alternative to antibiotics.
Area of Science:
- Microbiology
- Virology
- Biotechnology
Background:
- Staphylococcus aureus is a significant cause of human and animal infections, including hospital-acquired infections.
- Increasing antibiotic resistance necessitates alternative therapeutic strategies.
- Bacteriophages, particularly polyvalent myoviruses, are promising candidates for phage therapy.
Purpose of the Study:
- To characterize the bacteriophage vB_SauM-fRuSau02 (fRuSau02) isolated from a commercial phage cocktail.
- To evaluate the host range and potential of fRuSau02 as a therapeutic agent against Staphylococcus aureus.
Main Methods:
- Genomic analysis of bacteriophage fRuSau02.
- Identification of structural and virion-associated proteins using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
- Host range testing against various Staphylococcus strains, including clinical isolates from humans and pigs.
Main Results:
- fRuSau02 possesses a large genome (148,464 bp) and belongs to the Twortlikevirus genus.
- 78 structural and virion-associated proteins were identified.
- The phage demonstrated sensitivity against clinical Staphylococcus aureus strains and some coagulase-negative staphylococci, with varying efficacy against pig strains.
Conclusions:
- fRuSau02 is a well-characterized bacteriophage with potential as a phage therapy agent.
- It offers a viable alternative to antibiotic treatment for Staphylococcus aureus infections.
- Further research into its application as a therapeutic agent is warranted.
More Related Videos
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
Subviral Agents

